Ultralife (ULBI) Stock Price, News & Analysis

Company Overview

Ultralife Corporation (NASDAQ: ULBI) develops, manufactures and sells a broad range of energy and communications products for defense, medical, automotive and consumer electronics markets. The company operates through two primary segments: Power Systems and Communications Systems. In its Power Systems segment, Ultralife produces lithium-ion rechargeable cells and battery packs, primary lithium batteries, alkaline and rechargeable battery packs, chargers and battery accessories designed to meet demanding performance and safety requirements. Its Communications Systems segment offers tactical communications solutions, including voice and data transmission systems, power management units and air purification systems primarily for military and public safety organizations.

Founded in the late 1980s and headquartered in Newark, New York, Ultralife has built a reputation for delivering rugged, reliable energy and communication solutions that comply with stringent defense and industrial standards. Over the years, the company has invested in research and development to expand its product portfolio, pursue higher energy density chemistries and improve battery management technologies. Ultralife’s manufacturing facilities and design centers are ISO-certified and employ automated production processes to maintain quality, traceability and consistency across all product lines.

Ultralife serves customers around the globe, with sales and support operations in North America, Europe and Asia. Its energy solutions power critical applications such as battlefield radios, unmanned vehicles, medical monitoring devices and electric vehicle charging systems, while its communications products are used in environments that demand secure, continuous voice and data connectivity. The company’s customer base includes major defense contractors, equipment manufacturers and end users in the public safety sector.

Ultralife is led by an experienced management team and board of directors with deep expertise in battery technology, electronics engineering and global supply chain management. The company continues to pursue strategic collaborations and acquisitions to enhance its technology offerings, expand its geographic footprint and capture new growth opportunities in renewable energy and next-generation communications markets.

Key Stats

• Today's Range: $6.68 to $6.87
• 50-Day Range: $6.51 to $9.13
• 52-Week Range: $4.07 to $10.09
• Volume: 62,738 shs
• Average Volume: 78,201 shs
• Market Capitalization: $113.07 million
• P/E Ratio: 35.77
• Dividend Yield: N/A
• Price Target: $14.00
• Consensus Rating: Buy

Ultralife Stock Analysis - MarketRank™

Ultralife scored higher than 74% of companies evaluated by MarketBeat, and ranked 214th out of 646 stocks in the computer and technology sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 3.5 / 5
• Analyst Rating: Buy

Consensus Rating

Ultralife has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.

Upside Potential

Ultralife has a consensus price target of $14.00, representing about 105.4% upside from its current price of $6.82.

Amount of Analyst Coverage

Ultralife has received no research coverage in the past 90 days.

Earnings and Valuation

• Score: 1.9 / 5
• Proj. Earnings Growth: N/A

Price to Earnings Ratio vs. the Market

The P/E ratio of Ultralife is 35.87, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 280.47.

Price to Earnings Ratio vs. Sector

The P/E ratio of Ultralife is 35.87, which means that it is trading at a less expensive P/E ratio than the Computer and Technology sector average P/E ratio of about 441.34.

Price to Book Value per Share Ratio

Ultralife has a P/B Ratio of 0.84. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

Short Interest

• Score: 4.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

1.58% of the float of Ultralife has been sold short.

Short Interest Ratio / Days to Cover

Ultralife has a short interest ratio ("days to cover") of 1.6, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Ultralife has recently decreased by 3.24%, indicating that investor sentiment is improving.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Ultralife does not currently pay a dividend.

Dividend Growth

Ultralife does not have a long track record of dividend growth.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Percentage of Shares Shorted

1.58% of the float of Ultralife has been sold short.

Short Interest Ratio / Days to Cover

Ultralife has a short interest ratio ("days to cover") of 1.6, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Ultralife has recently decreased by 3.24%, indicating that investor sentiment is improving.

News and Social Media

• Score: 2.2 / 5
• News Sentiment: 1.00

News Sentiment

Ultralife has a news sentiment score of 1.00. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Computer and Technology companies.

News Coverage This Week

MarketBeat has tracked 4 news articles for Ultralife this week, compared to 2 articles on an average week.

MarketBeat Follows

Only 1 people have added Ultralife to their MarketBeat watchlist in the last 30 days. This is a decrease of -67% compared to the previous 30 days.

Company Ownership

• Score: 3.3 / 5
• Insider Trading: Acquiring Shares

Insider Buying vs. Insider Selling

In the past three months, Ultralife insiders have bought more of their company's stock than they have sold. Specifically, they have bought $387,049.00 in company stock and sold $0.00 in company stock.

Percentage Held by Insiders

40.00% of the stock of Ultralife is held by insiders. A high percentage of insider ownership can be a sign of company health.

Percentage Held by Institutions

Only 30.68% of the stock of Ultralife is held by institutions.

ULBI Stock Analysis - Frequently Asked Questions

How have ULBI shares performed this year?

Ultralife's stock was trading at $7.45 at the beginning of the year. Since then, ULBI stock has decreased by 8.5% and is now trading at $6.8150.

How were Ultralife's earnings last quarter?

Ultralife Corporation (NASDAQ:ULBI) announced its quarterly earnings results on Thursday, August, 7th. The technology company reported $0.07 earnings per share for the quarter, missing the consensus estimate of $0.14 by $0.07. The technology company had revenue of $48.56 million for the quarter, compared to analysts' expectations of $51 million. Ultralife had a net margin of 1.79% and a trailing twelve-month return on equity of 2.68%.
Read the conference call transcript.

Does Ultralife have any subsidiaries?

Ultralife subsidiaries include these companies: ABLE New Energy Co. Limited, Accutronics Ltd., CLB Inc., Southwest Electronic Energy Corporation, Ultralife Batteries India Private Limited, Ultralife Batteries (UK) LTD, Ultralife Energy Services Corporation, and Ultralife UK LTD.

Who are Ultralife's major shareholders?

Ultralife's top institutional investors include Janney Montgomery Scott LLC (2.68%), Truffle Hound Capital LLC (1.50%), RBF Capital LLC (1.35%) and Connor Clark & Lunn Investment Management Ltd. (0.88%). Insiders that own company stock include Bradford T Whitmore, Thomas Louis Saeli, W Shaw Robert, Michael Edward Manna and Janie Goddard.
View institutional ownership trends.

How do I buy shares of Ultralife?

Shares of ULBI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Ultralife own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Ultralife investors own include NVIDIA (NVDA), Broadcom (AVGO), Meta Platforms (META), Arista Networks (ANET), e.l.f. Beauty (ELF), Jabil (JBL) and Adobe (ADBE).

Company Calendar

• Last Earnings: 8/07/2025
• Today: 9/11/2025
• Next Earnings (Estimated): 11/07/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Computer and Technology
• Industry: ELEC - MISC COMPONENTS
• Sub-Industry: Electrical Equipment
• Current Symbol: NASDAQ:ULBI
• CIK: 875657
• Web: www.ultralifecorporation.com
• Phone: (315) 332-7100
• Fax: 315-331-7800
• Employees: 560
• Year Founded: 1990

Price Target and Rating

• Average Price Target for Ultralife: $14.00
• High Price Target: $14.00
• Low Price Target: $14.00
• Potential Upside/Downside: +109.0%
• Consensus Rating: Buy
• Rating Score (0-4): 3.00
• Research Coverage: 1 Analysts

Profitability

• EPS (Trailing Twelve Months): $0.19
• Trailing P/E Ratio: 35.27
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: $6.31 million
• Net Margins: 1.79%
• Pretax Margin: 2.46%
• Return on Equity: 2.68%
• Return on Assets: 1.74%

Debt

• Debt-to-Equity Ratio: 0.34
• Current Ratio: 3.31
• Quick Ratio: 1.62

Sales & Book Value

• Annual Sales: $164.46 million
• Price / Sales: 0.68
• Cash Flow: $0.72 per share
• Price / Cash Flow: 9.26
• Book Value: $8.07 per share
• Price / Book: 0.83

Miscellaneous

• Outstanding Shares: 16,640,000
• Free Float: 9,986,000
• Market Cap: $111.49 million
• Optionable: No Data
• Beta: 1.08